126 related articles for article (PubMed ID: 3125115)
1. Anticoagulation clinics and the monitoring of anticoagulant therapy.
Charney R; Leddomado E; Rose DN; Fuster V
Int J Cardiol; 1988 Feb; 18(2):197-206. PubMed ID: 3125115
[TBL] [Abstract][Full Text] [Related]
2. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.
Larson BJ; Zumberg MS; Kitchens CS
Chest; 2005 Mar; 127(3):922-7. PubMed ID: 15764777
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group.
Fihn SD; McDonell M; Martin D; Henikoff J; Vermes D; Kent D; White RH
Ann Intern Med; 1993 Apr; 118(7):511-20. PubMed ID: 8280198
[TBL] [Abstract][Full Text] [Related]
4. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
Poon IO; Lal L; Brown EN; Braun UK
J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
[TBL] [Abstract][Full Text] [Related]
5. Prothrombin time ratio and other factors associated with bleeding in patients treated with warfarin.
Petitti DB; Strom BL; Melmon KL
J Clin Epidemiol; 1989; 42(8):759-64. PubMed ID: 2760667
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor.
Kearon C; Ginsberg JS; Anderson DR; Kovacs MJ; Wells P; Julian JA; Mackinnon B; Demers C; Douketis J; Turpie AG; Van Nguyen P; Green D; Kassis J; Kahn SR; Solymoss S; Desjardins L; Geerts W; Johnston M; Weitz JI; Hirsh J; Gent M;
J Thromb Haemost; 2004 May; 2(5):743-9. PubMed ID: 15099280
[TBL] [Abstract][Full Text] [Related]
7. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy.
Palareti G; Leali N; Coccheri S; Poggi M; Manotti C; D'Angelo A; Pengo V; Erba N; Moia M; Ciavarella N; Devoto G; Berrettini M; Musolesi S
Lancet; 1996 Aug; 348(9025):423-8. PubMed ID: 8709780
[TBL] [Abstract][Full Text] [Related]
8. The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics.
Fihn SD; Callahan CM; Martin DC; McDonell MB; Henikoff JG; White RH
Ann Intern Med; 1996 Jun; 124(11):970-9. PubMed ID: 8624064
[TBL] [Abstract][Full Text] [Related]
9. [Hemorrhagic complications of oral anticoagulant therapy: results of a prospective multicenter study ISCOAT (Italian Study on Complications of Oral Anticoagulant Therapy)].
Palareti G; Leali N; Coccheri S; Poggi M; Manotti C; D'Angelo A; Pengo V; Erba N; Moia M; Ciavarella N; Devoto G; Berretini M; Musolesi S
G Ital Cardiol; 1997 Mar; 27(3):231-43. PubMed ID: 9244725
[TBL] [Abstract][Full Text] [Related]
10. The long-term risk of warfarin sodium therapy and the incidence of thromboembolism in children after prosthetic cardiac valve replacement.
Stewart S; Cianciotta D; Alexson C; Manning J
J Thorac Cardiovasc Surg; 1987 Apr; 93(4):551-4. PubMed ID: 3561002
[TBL] [Abstract][Full Text] [Related]
11. Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trial.
Onundarson PT; Francis CW; Indridason OS; Arnar DO; Bjornsson ES; Magnusson MK; Juliusson SJ; Jensdottir HM; Vidarsson B; Gunnarsson PS; Lund SH; Gudmundsdottir BR
Lancet Haematol; 2015 Jun; 2(6):e231-40. PubMed ID: 26688233
[TBL] [Abstract][Full Text] [Related]
12. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.
Kearon C; Gent M; Hirsh J; Weitz J; Kovacs MJ; Anderson DR; Turpie AG; Green D; Ginsberg JS; Wells P; MacKinnon B; Julian JA
N Engl J Med; 1999 Mar; 340(12):901-7. PubMed ID: 10089183
[TBL] [Abstract][Full Text] [Related]
13. Reduced anticoagulation variability in patients on warfarin monitored with Fiix-prothrombin time associates with reduced thromboembolism: The Fiix-trial.
Oskarsdóttir AR; Gudmundsdottir BR; Indridason OS; Lund SH; Arnar DO; Bjornsson ES; Magnusson MK; Jensdottir HM; Vidarsson B; Francis CW; Onundarson PT
J Thromb Thrombolysis; 2017 May; 43(4):550-561. PubMed ID: 28214948
[TBL] [Abstract][Full Text] [Related]
14. Extended oral anticoagulant therapy after a first episode of pulmonary embolism.
Agnelli G; Prandoni P; Becattini C; Silingardi M; Taliani MR; Miccio M; Imberti D; Poggio R; Ageno W; Pogliani E; Porro F; Zonzin P;
Ann Intern Med; 2003 Jul; 139(1):19-25. PubMed ID: 12834314
[TBL] [Abstract][Full Text] [Related]
15. The safety and effectiveness of long-term warfarin therapy in an anticoagulation clinic.
Bussey HI; Rospond RM; Quandt CM; Clark GM
Pharmacotherapy; 1989; 9(4):214-9. PubMed ID: 2788876
[TBL] [Abstract][Full Text] [Related]
16. Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial.
Couturaud F; Sanchez O; Pernod G; Mismetti P; Jego P; Duhamel E; Provost K; dit Sollier CB; Presles E; Castellant P; Parent F; Salaun PY; Bressollette L; Nonent M; Lorillon P; Girard P; Lacut K; Guégan M; Bosson JL; Laporte S; Leroyer C; Décousus H; Meyer G; Mottier D;
JAMA; 2015 Jul; 314(1):31-40. PubMed ID: 26151264
[TBL] [Abstract][Full Text] [Related]
17. A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial.
Beyth RJ; Quinn L; Landefeld CS
Ann Intern Med; 2000 Nov; 133(9):687-95. PubMed ID: 11074901
[TBL] [Abstract][Full Text] [Related]
18. Complications of warfarin therapy monitored by the International Normalized Ratio versus the prothrombin time ratio.
Andrews TC; Peterson DW; Doeppenschmidt D; Foster JS; Lucca MJ; Deering JA; LaVeau PJ
Clin Cardiol; 1995 Feb; 18(2):80-2. PubMed ID: 7720294
[TBL] [Abstract][Full Text] [Related]
19. Rivaroxaban vs. warfarin on extended deep venous thromboembolism treatment: A cost analysis.
Diken AI; Yalçınkaya A; Hanedan MO; Erol ME; Ercen Diken Ö
Phlebology; 2018 Feb; 33(1):53-59. PubMed ID: 28056701
[TBL] [Abstract][Full Text] [Related]
20. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge.
Colwell CW; Collis DK; Paulson R; McCutchen JW; Bigler GT; Lutz S; Hardwick ME
J Bone Joint Surg Am; 1999 Jul; 81(7):932-40. PubMed ID: 10428124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
